PT3694526T - Resgate independente do genótipo da fibrose quística com canais de bicarbonato de moléculas pequenas - Google Patents

Resgate independente do genótipo da fibrose quística com canais de bicarbonato de moléculas pequenas

Info

Publication number
PT3694526T
PT3694526T PT188654834T PT18865483T PT3694526T PT 3694526 T PT3694526 T PT 3694526T PT 188654834 T PT188654834 T PT 188654834T PT 18865483 T PT18865483 T PT 18865483T PT 3694526 T PT3694526 T PT 3694526T
Authority
PT
Portugal
Prior art keywords
agnostic
genotype
rescue
bicarbonate
channels
Prior art date
Application number
PT188654834T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Univ Illinois
Univ Iowa Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois, Univ Iowa Res Found filed Critical Univ Illinois
Publication of PT3694526T publication Critical patent/PT3694526T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT188654834T 2017-10-11 2018-10-11 Resgate independente do genótipo da fibrose quística com canais de bicarbonato de moléculas pequenas PT3694526T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762570795P 2017-10-11 2017-10-11

Publications (1)

Publication Number Publication Date
PT3694526T true PT3694526T (pt) 2025-01-20

Family

ID=66100102

Family Applications (1)

Application Number Title Priority Date Filing Date
PT188654834T PT3694526T (pt) 2017-10-11 2018-10-11 Resgate independente do genótipo da fibrose quística com canais de bicarbonato de moléculas pequenas

Country Status (10)

Country Link
US (3) US12090164B2 (enExample)
EP (1) EP3694526B1 (enExample)
JP (2) JP7355335B2 (enExample)
AU (2) AU2018348214C1 (enExample)
CA (1) CA3076246A1 (enExample)
DK (1) DK3694526T3 (enExample)
ES (1) ES3009563T3 (enExample)
FI (1) FI3694526T3 (enExample)
PT (1) PT3694526T (enExample)
WO (1) WO2019075214A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI3694526T3 (fi) 2017-10-11 2025-02-06 Univ Illinois Genotyypistä riippumaton toimintakyvyn palautus pienimolekyylisillä bikarbonaattikanavilla kystistä fibroosia varten
WO2023183297A1 (en) 2022-03-21 2023-09-28 The Board Of Trustees Of The University Of Illinois Ion channel prosthetic compositions comprising lipid-coated crystals of amphotericin b
WO2025019806A2 (en) * 2023-07-19 2025-01-23 The Board Of Trustees Of The University Of Illinois Restoring physiology with small molecule mimics of missing proteins
WO2025064626A1 (en) * 2023-09-20 2025-03-27 The Board Of Trustees Of The University Of Illinois Additive effects for molecular prosthetcs and cftr modulators in cf epithelia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU598958B2 (en) * 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
NZ241954A (en) 1991-03-15 1994-01-26 Amgen Inc Compositions of g-csf for pulmonary administration.
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
KR101301653B1 (ko) * 2002-10-29 2013-08-30 트랜세이브, 인코포레이티드 항감염제의 지속적인 방출
TWI249408B (en) * 2003-12-10 2006-02-21 Ind Tech Res Inst New antifungal formulation and manufacturing method thereof
AU2005251572B2 (en) * 2004-06-11 2010-03-11 Lifecare Innovations Pvt. Ltd Sterol enriched mixed lammelarity Amphotericin intercalating liposomes in saline and the process for their preparation
US8507441B2 (en) * 2009-10-22 2013-08-13 University of Pittsburgh—Of the Commonwealth Systems of Higher Education Use of endostatin peptides for the treatment of fibrosis
US8945605B2 (en) 2011-06-07 2015-02-03 Parion Sciences, Inc. Aerosol delivery systems, compositions and methods
WO2016073462A1 (en) * 2014-11-04 2016-05-12 The Board Of Trustees Of The University Of Illinois Restoring physiology with small molecule mimics of missing proteins
PT3439668T (pt) * 2016-04-08 2024-08-12 Univ Illinois Restauração da fisiologia da superfície das vias aéreas mediada por pequenas moléculas no epitélio pulmonar da fibrose quística humana
CN109152747A (zh) * 2016-04-15 2019-01-04 Uab研究基金会 用于刺激提前终止密码子的通读的方法和化合物
FI3694526T3 (fi) 2017-10-11 2025-02-06 Univ Illinois Genotyypistä riippumaton toimintakyvyn palautus pienimolekyylisillä bikarbonaattikanavilla kystistä fibroosia varten

Also Published As

Publication number Publication date
WO2019075214A3 (en) 2020-04-02
JP2023126932A (ja) 2023-09-12
EP3694526B1 (en) 2024-12-04
AU2024259758A1 (en) 2024-11-21
CA3076246A1 (en) 2019-04-18
EP3694526A4 (en) 2021-06-09
US20250009775A1 (en) 2025-01-09
US20250000886A1 (en) 2025-01-02
DK3694526T3 (da) 2025-02-03
AU2018348214B2 (en) 2024-08-08
WO2019075214A2 (en) 2019-04-18
ES3009563T3 (en) 2025-03-27
AU2018348214C1 (en) 2025-01-30
JP7355335B2 (ja) 2023-10-03
JP2020536859A (ja) 2020-12-17
US12090164B2 (en) 2024-09-17
FI3694526T3 (fi) 2025-02-06
AU2018348214A1 (en) 2020-04-23
EP3694526A2 (en) 2020-08-19
US20200352970A1 (en) 2020-11-12

Similar Documents

Publication Publication Date Title
IL279460A (en) Modulators of the cystic fibrosis transmembrane conductance regulator
IL272032A (en) Methods of treatment for cystic fibrosis
IL271181A (en) Methods of treatment for cystic fibrosis
PL3436446T3 (pl) Modulatory mukowiscydozowego przezbłonowego regulatora przewodnictwa
EP3012003A4 (en) Combined toy gyroscope capable of being freely assembled
ZA201901252B (en) Activity-triggered provisioning of portable wireless networks
ZA201902929B (en) Gas inflatable balloons
IL252818A0 (en) Cyclopropanecarboxamides that modulate cystic fibrosis transmembrane conductance regulation
EP3012004A4 (en) Toy gyroscope with gyroscope ring capable of being mounted on both sides
IL262141B (en) A method for diagnosing cystic fibrosis
DK3694526T3 (da) Genotype-agnostisk redning af cystisk fibrose med småmolekylære bicarbonatkanaler
EP3536343A4 (en) SKIN FIBROSIS TREATMENT AGENT
CA3291070A1 (en) Portable foam brush
EP3392424A4 (en) LIGHTWEIGHT WALL BODY FRAME
EP3596067C0 (en) NEW PYRAZOLE DERIVATIVES FOR THE TREATMENT OF CYSTIC FIBROSIS
EP3508630A4 (en) SHELL FABRIC WITH MOTION TRACKING
EP3240461A4 (en) Personal applicator
GB201721718D0 (en) Treatment of cystic fibrosis
ZA201807388B (en) Pesticidally active mixtures of tioxazafen
HK40089592A (en) Modulators of cystic fibrosis transmembrane conductance regulator
TWM533984U (en) Detachable massage roller structure
EP3326662A4 (en) USE OF POROUS MATERIAL
AU201816640S (en) Hedgehog toy
HK1245655A1 (en) Cyclopropanecarboxamide modulators of cystic fibrosis transmembrane conductance regulator
GB201700824D0 (en) Sustained propulsion